Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
JXHL1900243 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-09-27 | AbbVie Inc. | Abbvie Inc | In Review | 2019-09-26 | view |
JXHL1900244 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-09-27 | AbbVie Inc. | Abbvie Inc | In Review | 2019-09-26 | view |
JXHL1900309 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-11-13 | AbbVie Inc. | Abbvie Inc | In Review | 2019-11-12 | view |
JXHL2000263 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-23 | AbbVie Inc. | Abbvie Inc | In Review | 2020-09-22 | view |
JXHL2000262 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-23 | AbbVie Inc. | Abbvie Inc | In Review | 2020-09-22 | view |
JXHB2101022 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2021-06-04 | Abbvie Inc | view | |||
JXHB2101121 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2021-12-28 | Abbvie Inc | view | |||
JXHL2200169 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2022-07-04 | Abbvie Inc | view | |||
JXHL2200247 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2022-08-18 | Abbvie Inc | view | |||
JXHL2200311 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2022-10-27 | Abbvie Inc | view | |||
JXHL2200312 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2022-10-27 | Abbvie Inc | view | |||
JXHL2300034 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-02-24 | Abbvie Inc | view | |||
JXHL2300055 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-03-23 | Abbvie Inc | view | |||
JXHL2300056 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-03-23 | Abbvie Inc | view | |||
JXHL2300133 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-05-30 | Abbvie Inc | view | |||
JXHL2300132 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-05-30 | Abbvie Inc | view | |||
JXHL2300134 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-06-01 | Abbvie Inc | view | |||
JXHL2300157 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-07-04 | Abbvie Inc | view | |||
JXHL2300158 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-07-04 | Abbvie Inc | view | |||
JXHB2300132 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2023-08-23 | Abbvie Inc;Abbvie Ireland Nl BV | view |